Search Results

There are 3617 results for: content related to: Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab

  1. Alemtuzumab for patients with chronic lymphocytic leukaemia

    Intervention Review

    The Cochrane Library

    Nicole Skoetz, Kathrin Bauer, Thomas Elter, Ina Monsef, Verena Roloff, Michael Hallek and Andreas Engert

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD008078.pub2

  2. Alemtuzumab (MabCampath)

    Handbook of Therapeutic Antibodies

    Thomas Elter, Andreas Engert, Michael Hallek, Pages: 733–777, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch28

  3. The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients

    Pediatric Transplantation

    Volume 18, Issue 1, February 2014, Pages: 94–102, Pooja Khandelwal, Julia Lawrence, Alexandra H. Filipovich, Stella M. Davies, Jacob J. Bleesing, Michael B. Jordan, Parinda Mehta, Sonata Jodele, Michael S. Grimley, Ashish Kumar, Kasiani Myers and Rebecca A. Marsh

    Article first published online : 30 OCT 2013, DOI: 10.1111/petr.12183

  4. You have free access to this content
    Investigation of Lymphocyte Depletion and Repopulation Using Alemtuzumab (Campath-1H) in Cynomolgus Monkeys

    American Journal of Transplantation

    Volume 10, Issue 4, April 2010, Pages: 773–783, D. J. Van Der Windt, C. Smetanka, C. Macedo, J. He, R. Lakomy, R. Bottino, B. Ekser, G. J. Echeverri, D. Metes, J. N. M. Ijzermans, M. Trucco, D. K. C. Cooper and F. G. Lakkis

    Article first published online : 20 MAR 2010, DOI: 10.1111/j.1600-6143.2010.03050.x

  5. You have free access to this content
    Rediscovering alemtuzumab: current and emerging therapeutic roles

    British Journal of Haematology

    Volume 144, Issue 6, March 2009, Pages: 818–831, John G. Gribben and Michael Hallek

    Article first published online : 12 JAN 2009, DOI: 10.1111/j.1365-2141.2008.07557.x

  6. The Role of Alemtuzumab in Solid Organ Transplantation

    Immunotherapy in Transplantation: Principles and Practice

    Avinash Agarwal, David Bruno, Stuart J. Knechtle, Pages: 346–361, 2012

    Published Online : 19 APR 2012, DOI: 10.1002/9781444355628.ch23

  7. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab

    Pediatric Blood & Cancer

    Volume 60, Issue 1, January 2013, Pages: 101–109, Rebecca A. Marsh, Carl E. Allen, Kenneth L. McClain, Joanna L. Weinstein, Julie Kanter, Jodi Skiles, Nadine D. Lee, Shakila P. Khan, Julia Lawrence, Jun Q. Mo, Jack J. Bleesing, Alexandra H. Filipovich and Michael B. Jordan

    Article first published online : 22 APR 2012, DOI: 10.1002/pbc.24188

  8. You have free access to this content
    Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma


    Volume 112, Issue 6, 15 March 2008, Pages: 1288–1295, John D. Hainsworth, Elizabeth R. Vazquez, David R. Spigel, Eric Raefsky, James D. Bearden, Ruben A. Saez and F. Anthony Greco

    Article first published online : 11 JAN 2008, DOI: 10.1002/cncr.23271

  9. You have free access to this content
    Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy

    British Journal of Haematology

    Volume 145, Issue 2, April 2009, Pages: 173–179, Liuyan Jiang, Constance M. Yuan, Julia Hubacheck, John E. Janik, Wyndham Wilson, John C. Morris, Gregory A. Jasper and Maryalice Stetler-Stevenson

    Article first published online : 19 FEB 2009, DOI: 10.1111/j.1365-2141.2009.07606.x

  10. You have free access to this content
    Alemtuzumab in the Treatment of Refractory Acute Rejection and Bronchiolitis Obliterans Syndrome After Human Lung Transplantation

    American Journal of Transplantation

    Volume 7, Issue 12, December 2007, Pages: 2802–2808, B. D. Reams, L. W. Musselwhite, D. W. Zaas, M. P. Steele, S. Garantziotis, P. C. Eu, L. D. Snyder, J. Curl, S. S. Lin, R. D. Davis and S. M. Palmer

    Article first published online : 30 OCT 2007, DOI: 10.1111/j.1600-6143.2007.02000.x

  11. You have free access to this content
    Self-administered, subcutaneous alemtuzumab to treat residual disease in patients with chronic lymphocytic leukemia


    Volume 117, Issue 1, 1 January 2011, Pages: 116–124, William G. Wierda, Thomas J. Kipps, Michael J. Keating, Jennifer R. Brown, John G. Gribben, Mary Browning, Laura Z. Rassenti, Andrew W. Greaves, Donna Neuberg, Susan M. O'Brien and and the CLL Research Consortium

    Article first published online : 30 AUG 2010, DOI: 10.1002/cncr.25379

  12. You have free access to this content
    Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro


    Volume 141, Issue 1, January 2014, Pages: 123–131, Evis Havari, Michael J. Turner, Juanita Campos-Rivera, Srinivas Shankara, Tri-Hung Nguyen, Bruce Roberts, William Siders and Johanne M. Kaplan

    Article first published online : 10 DEC 2013, DOI: 10.1111/imm.12178

  13. You have free access to this content
    Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia


    Volume 107, Issue 10, 15 November 2006, Pages: 2408–2416, Michael Fiegl, Andreas Falkner, Georg Hopfinger, Stefan Brugger, August Zabernigg, Franz Bauer, Ferdinand Haslbauer, Dita Demirtas, Peter Grossschmidt, Georg Tatzreiter, Günther Gastl, Richard Greil and The Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia

    Article first published online : 19 OCT 2006, DOI: 10.1002/cncr.22263

  14. You have free access to this content
    Ex Vivo-Expanded Cynomolgus Macaque Regulatory T Cells Are Resistant to Alemtuzumab-Mediated Cytotoxicity

    American Journal of Transplantation

    Volume 13, Issue 8, August 2013, Pages: 2169–2178, E. M. Dons, G. Raimondi, H. Zhang, A. F. Zahorchak, J. K. Bhama, L. Lu, M. Ezzelarab, J. N. M. Ijzermans, D. K. C. Cooper and A. W. Thomson

    Article first published online : 1 MAY 2013, DOI: 10.1111/ajt.12248

  15. You have free access to this content
    An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

    British Journal of Haematology

    Volume 156, Issue 4, February 2012, Pages: 481–489, Agostino Cortelezzi, Giuseppe Gritti, Luca Laurenti, Antonio Cuneo, Stefania Ciolli, Nicola Di Renzo, Pellegrino Musto, Francesca R. Mauro, Nicola Cascavilla, Lorenzo Falchi, Francesco Zallio, Vincenzo Callea, Francesco Maura, Sara Martinelli, Alfonso Piciocchi, Gianluigi Reda, Robin Foà and on behalf of the GIMEMA Chronic Lymphoproliferative Disorders Working Party

    Article first published online : 9 DEC 2011, DOI: 10.1111/j.1365-2141.2011.08965.x

  16. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal

    Clinical Transplantation

    Harrison E. Saull, Cher Y. Enderby, Thomas A. Gonwa and Hani M. Wadei

    Article first published online : 24 MAR 2015, DOI: 10.1111/ctr.12532

  17. You have free access to this content
    Alemtuzumab as compared to alternative contemporary induction regimens

    Transplant International

    Volume 25, Issue 5, May 2012, Pages: 518–526, John C. LaMattina, Joshua D. Mezrich, R. Michael Hofmann, David P. Foley, Anthony M. D’Alessandro, Hans W. Sollinger and John D. Pirsch

    Article first published online : 6 MAR 2012, DOI: 10.1111/j.1432-2277.2012.01448.x

  18. Alemtuzumab in lymphoproliferate disorders

    Reviews in Clinical and Experimental Hematology

    Volume 6, Issue 4, December 2002, Pages: 435–448,

    Article first published online : 29 MAY 2003, DOI: 10.1046/j.1468-0734.2002.00308.x

  19. You have free access to this content
    Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)

    British Journal of Haematology

    Volume 153, Issue 4, May 2011, Pages: 451–485, Claire E. Dearden, Rod Johnson, Ruth Pettengell, Stephen Devereux, Kate Cwynarski, Sean Whittaker, Andrew McMillan and British Committee for Standards in Haematology

    Article first published online : 11 APR 2011, DOI: 10.1111/j.1365-2141.2011.08651.x

  20. You have free access to this content
    Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia


    Volume 119, Issue 12, 15 June 2013, Pages: 2258–2267, Georg Hopfinger, Raymonde Busch, Natali Pflug, Nicole Weit, Anne Westermann, Anna-Maria Fink, Paula Cramer, Nina Reinart, Dirk Winkler, Günter Fingerle-Rowson, Stephan Stilgenbauer, Hartmut Döhner, Gabriele Kandler, Barbara Eichhorst, Michael Hallek and Marco Herling

    Article first published online : 19 MAR 2013, DOI: 10.1002/cncr.27972